Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
12.06%
operating margin TTM
14.95%
revenue TTM
406.96 Million
revenue per share TTM
3.18$
valuation ratios | |
|---|---|
| pe ratio | 38.80 |
| peg ratio | 0.07 |
| price to book ratio | 12.46 |
| price to sales ratio | 4.75 |
| enterprise value multiple | 29.26 |
| price fair value | 12.46 |
profitability ratios | |
|---|---|
| gross profit margin | 90.12% |
| operating profit margin | 14.95% |
| pretax profit margin | 12.23% |
| net profit margin | 12.06% |
| return on assets | 12.31% |
| return on equity | 39.71% |
| return on capital employed | 20.68% |
liquidity ratios | |
|---|---|
| current ratio | 3.63 |
| quick ratio | 3.16 |
| cash ratio | 1.43 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 439.39 |
| operating cycle | 586.38 |
| days of payables outstanding | 164.01 |
| cash conversion cycle | 422.38 |
| receivables turnover | 2.48 |
| payables turnover | 2.23 |
| inventory turnover | 0.83 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | 1.15 |
| long term debt to capitalization | 0.47 |
| total debt to capitalization | 0.53 |
| interest coverage | 3.79 |
| cash flow to debt ratio | 0.08 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.30 |
| cash per share | 3.23 |
| operating cash flow per share | 0.30 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.08 |
| short term coverage ratios | 0.38 |
| capital expenditure coverage ratio | 4,721.38 |
Frequently Asked Questions
When was the last time Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) reported earnings?
Apellis Pharmaceuticals, Inc. (APLS) published its most recent earnings results on 07-05-2026.
What is Apellis Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)'s trailing twelve months ROE is 39.71%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Apellis Pharmaceuticals, Inc. (APLS) currently has a ROA of 12.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did APLS's net profit margin stand at?
APLS reported a profit margin of 12.06% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is APLS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.63 in the most recent quarter. The quick ratio stood at 3.16, with a Debt/Eq ratio of 1.15.